PSB-CB5 [Ligand Id: 14605] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL3221188
  • CB1 receptor/Cannabinoid receptor 1 in Human [ChEMBL: CHEMBL218] [GtoPdb: 56] [UniProtKB: P21554]
  • CB1 receptor/Cannabinoid receptor 1 in Rat [ChEMBL: CHEMBL3571] [GtoPdb: 56] [UniProtKB: P20272]
There should be some charts here, you may need to enable JavaScript!
  • CB2 receptor/Cannabinoid receptor 2 in Human [ChEMBL: CHEMBL253] [GtoPdb: 57] [UniProtKB: P34972]
There should be some charts here, you may need to enable JavaScript!
There should be some charts here, you may need to enable JavaScript!
There should be some charts here, you may need to enable JavaScript!
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
CB1 receptor/Cannabinoid receptor 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL218] [GtoPdb: 56] [UniProtKB: P21554]
ChEMBL Displacement of [3H]CP55,940 from human recombinant CB1 receptor expressed in CHO-K1 cells B 5 pKi >10000 nM Ki Medchemcomm (2014) 5: 632-649
CB1 receptor/Cannabinoid receptor 1 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3571] [GtoPdb: 56] [UniProtKB: P20272]
ChEMBL Displacement of [3H]CP55,940 from CB1 receptor in rat brain cortical membranes B 5.08 pKi 8240 nM Ki Medchemcomm (2014) 5: 632-649
CB2 receptor/Cannabinoid receptor 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL253] [GtoPdb: 57] [UniProtKB: P34972]
GtoPdb - - 5.39 pKi 4030 nM Ki Eur J Med Chem (2018) 155: 381-397 [PMID:29902723]
ChEMBL Displacement of [3H]CP55,940 from human recombinant CB2 receptor expressed in HEK293 cells B 5.39 pKi 4030 nM Ki Medchemcomm (2014) 5: 632-649
GPR35/G-protein coupled receptor 35 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1293267] [GtoPdb: 102] [UniProtKB: Q9HC97]
ChEMBL Antagonist activity at human GPR35 assessed as reduction of zaprinast-induced beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation method B 5 pIC50 >10000 nM IC50 Medchemcomm (2014) 5: 632-649
ChEMBL Agonist activity at human GPR35 assessed as induction of beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation method B 5 pEC50 >10000 nM EC50 Medchemcomm (2014) 5: 632-649
GPR55/G-protein coupled receptor 55 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075322] [GtoPdb: 109] [UniProtKB: Q9Y2T6]
ChEMBL Antagonist activity against human GPR55 expressed in CHO cells assessed as reduction in LPI-induced beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation method B 5 pIC50 >10000 nM IC50 Medchemcomm (2014) 5: 632-649
GPR18/N-arachidonyl glycine receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2384898] [GtoPdb: 89] [UniProtKB: Q14330]
GtoPdb Measuring inhibition of β-arrestin recruitment by tetrahydrocannabinol (THC)-activated human GPR18 - 6.55 pIC50 279 nM IC50 Eur J Med Chem (2018) 155: 381-397 [PMID:29902723]
ChEMBL Antagonist activity against human GPR18 expressed in CHO cells assessed as reduction in delta9-THC-induced beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation method B 6.55 pIC50 279 nM IC50 Medchemcomm (2014) 5: 632-649

ChEMBL data shown on this page come from version 37:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]